| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.552 | 0.002 | 0.552 | CYP2A6 inhibitor | |||
| 0.55 | 0.026 | 0.55 | Aldehyde oxidase inhibitor | |||
| 0.41 | 0.005 | 0.41 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | |||
| 0.379 | 0.004 | 0.379 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.369 | 0.005 | 0.369 | CDC-like kinase 1 inhibitor | |||
| 0.377 | 0.019 | 0.377 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | |||
| 0.422 | 0.064 | 0.422 | Histamine release inhibitor | |||
| 0.376 | 0.035 | 0.376 | Calcium channel activator | 0.323 0.071 CID_154699694 | ||
| 0.383 | 0.042 | 0.383 | Lipoxygenase inhibitor | |||
| 0.362 | 0.022 | 0.362 | 5 Hydroxytryptamine uptake stimulant | 0.203 0.145 CID_154699694 | ||
| 0.364 | 0.029 | 0.364 | Pyruvate kinase inhibitor | |||
| 0.43 | 0.098 | 0.43 | Transcription factor inhibitor | |||
| 0.394 | 0.064 | 0.394 | GABA C receptor rho-3 antagonist | |||
| 0.332 | 0.002 | 0.332 | Estradiol 17 beta-dehydrogenase 2 inhibitor | |||
| 0.394 | 0.065 | 0.394 | Calpain 2 inhibitor | |||
| 0.392 | 0.069 | 0.392 | Prostaglandin dehydrogenase inhibitor | |||
| 0.4 | 0.078 | 0.4 | 5 Hydroxytryptamine release inhibitor | |||
| 0.346 | 0.034 | 0.346 | Transcription factor STAT3 inhibitor | |||
| 0.343 | 0.037 | 0.343 | Transcription factor STAT inhibitor | |||
| 0.319 | 0.015 | 0.319 | Tumour necrosis factor antagonist | |||
| 0.366 | 0.07 | 0.366 | Thioredoxin glutathione reductase inhibitor | |||
| 0.411 | 0.115 | 0.411 | DNA polymerase beta inhibitor | |||
| 0.341 | 0.053 | 0.341 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.29 | 0.005 | 0.29 | Cell adhesion molecule inhibitor | |||
| 0.319 | 0.034 | 0.319 | Clk dual-specificity kinase inhibitor | |||
| 0.398 | 0.116 | 0.398 | DNA directed DNA polymerase inhibitor | |||
| 0.286 | 0.006 | 0.286 | Selectin antagonist | |||
| 0.32 | 0.044 | 0.32 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.279 | 0.014 | 0.279 | Interleukin 1 antagonist | |||
| 0.31 | 0.049 | 0.31 | Dyrk kinase inhibitor | |||
| 0.263 | 0.003 | 0.263 | VCAM antagonist | |||
| 0.261 | 0.003 | 0.261 | VCAM-1 antagonist | |||
| 0.381 | 0.123 | 0.381 | Caspase 9 stimulant | |||
| 0.288 | 0.039 | 0.288 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.314 | 0.073 | 0.314 | Streptokinase A inhibitor | |||
| 0.265 | 0.03 | 0.265 | I kappa B kinase epsilon inhibitor | |||
| 0.27 | 0.048 | 0.27 | Calpain inhibitor | |||
| 0.24 | 0.017 | 0.24 | 5-Lipoxygenase inhibitor | |||
| 0.222 | 0.004 | 0.222 | Sphingosine 1-phosphate receptor 5 agonist | |||
| 0.245 | 0.036 | 0.245 | Nitric-oxide synthase stimulant | |||
| 0.224 | 0.019 | 0.224 | Cell adhesion inhibitor | |||
| 0.236 | 0.032 | 0.236 | Histone acetyltransferase inhibitor | |||
| 0.297 | 0.093 | 0.297 | Cholesterol antagonist | |||
| 0.205 | 0.011 | 0.205 | Adenylate cyclase stimulant | 0.142 0.076 CID_154699694 | ||
| 0.194 | 0.004 | 0.194 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.194 | 0.004 | 0.194 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.196 | 0.009 | 0.196 | DNA repair enzyme inhibitor | |||
| 0.253 | 0.075 | 0.253 | Hypoglycemic | |||
| 0.205 | 0.028 | 0.205 | Mannose-6-phosphate isomerase inhibitor | |||
| 0.339 | 0.163 | 0.339 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.176 | 0.009 | 0.176 | Ca2+-transporting ATPase inhibitor | 0.148 0.046 CID_154699694 | ||
| 0.208 | 0.043 | 0.208 | Succinate dehydrogenase inhibitor | |||
| 0.17 | 0.005 | 0.17 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.211 | 0.046 | 0.211 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.197 | 0.035 | 0.197 | Alpha-N-acetylglucosaminidase inhibitor | 0.153 0.053 CID_154699694 | ||
| 0.177 | 0.016 | 0.177 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.212 | 0.058 | 0.212 | LIM domain kinase 1 inhibitor | |||
| 0.178 | 0.026 | 0.178 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.157 | 0.006 | 0.157 | Nicotinic receptor alpha7 subunit antagonist | |||
| 0.265 | 0.116 | 0.354 | Vasodilator, peripheral | 0.354 0.072 CID_154699694 | CID_154699694 | |
| 0.305 | 0.157 | 0.305 | Alpha-glucosidase inhibitor | |||
| 0.237 | 0.089 | 0.237 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.247 | 0.103 | 0.247 | Hypoxia-inducible factor 1 alpha inhibitor | |||
| 0.188 | 0.045 | 0.188 | Arachidonic acid antagonist | 0.159 0.078 CID_154699694 | ||
| 0.163 | 0.024 | 0.163 | Photosensitizer | |||
| 0.257 | 0.12 | 0.339 | Antithrombotic | 0.339 0.069 CID_154699694 | CID_154699694 | |
| 0.14 | 0.004 | 0.14 | Vanilloid 4 agonist | |||
| 0.279 | 0.144 | 0.279 | 15-Lipoxygenase inhibitor | |||
| 0.186 | 0.053 | 0.186 | Protein-tyrosine phosphatase inhibitor | |||
| 0.149 | 0.017 | 0.149 | Acetylcholine release stimulant | |||
| 0.214 | 0.084 | 0.214 | Cyclic AMP phosphodiesterase inhibitor | 0.162 0.134 CID_154699694 | ||
| 0.217 | 0.092 | 0.217 | Neuropeptide Y2 antagonist | |||
| 0.127 | 0.005 | 0.127 | Factor IXa inhibitor | |||
| 0.148 | 0.029 | 0.148 | Caspase 3 inhibitor | |||
| 0.121 | 0.004 | 0.121 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.266 | 0.149 | 0.266 | Beta lactamase inhibitor | |||
| 0.216 | 0.101 | 0.216 | Superoxide dismutase inhibitor | |||
| 0.18 | 0.067 | 0.18 | Mcl-1 antagonist | |||
| 0.122 | 0.012 | 0.122 | Histone deacetylase inhibitor | |||
| 0.113 | 0.005 | 0.113 | Exportin-1 inhibitor | |||
| 0.189 | 0.081 | 0.189 | Anesthetic general | |||
| 0.194 | 0.086 | 0.194 | MAP kinase kinase 2 inhibitor | |||
| 0.166 | 0.059 | 0.166 | NOS3 expression enhancer | |||
| 0.127 | 0.021 | 0.127 | Ornithine decarboxylase inhibitor | |||
| 0.125 | 0.02 | 0.125 | Alpha 2d adrenoreceptor antagonist | |||
| 0.137 | 0.032 | 0.137 | Potassium channel (Ca-activated) activator | |||
| 0.191 | 0.086 | 0.191 | Neurotrophic factor enhancer | |||
| 0.127 | 0.024 | 0.127 | Acetylcholine nicotinic agonist | |||
| 0.203 | 0.101 | 0.203 | Aryl hydrocarbon receptor agonist | |||
| 0.136 | 0.034 | 0.136 | UDP-glucose 4-epimerase inhibitor | |||
| 0.155 | 0.053 | 0.155 | MAP3K9 inhibitor | |||
| 0.139 | 0.039 | 0.154 | Mucolytic | 0.154 0.03 CID_154699694 | CID_154699694 | |
| 0.154 | 0.055 | 0.154 | Neurotrophic factor | |||
| 0.116 | 0.018 | 0.116 | GABA aminotransferase inhibitor | |||
| 0.116 | 0.019 | 0.116 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.103 | 0.006 | 0.103 | TRPM8 blocker | |||
| 0.207 | 0.116 | 0.207 | 5 Hydroxytryptamine release stimulant | |||
| 0.157 | 0.069 | 0.157 | Interferon gamma antagonist | 0.125 0.121 CID_154699694 | ||
| 0.115 | 0.029 | 0.115 | I kappa B kinase inhibitor | |||
| 0.128 | 0.041 | 0.128 | Carbonic anhydrase XV inhibitor | |||
| 0.176 | 0.09 | 0.176 | Non-steroidal antiinflammatory agent | |||
| 0.149 | 0.063 | 0.149 | Cytokine production inhibitor | |||
| 0.11 | 0.024 | 0.11 | Vanilloid agonist | |||
| 0.117 | 0.031 | 0.117 | Acetylcholine nicotinic antagonist | |||
| 0.235 | 0.15 | 0.257 | Vasodilator, coronary | 0.257 0.127 CID_154699694 | CID_154699694 | |
| 0.101 | 0.016 | 0.101 | NMDA receptor glycine site agonist | |||
| 0.106 | 0.024 | 0.106 | Estrogen receptor alpha antagonist | |||
| 0.147 | 0.065 | 0.147 | Toll-Like receptor 9 antagonist | |||
| 0.138 | 0.057 | 0.138 | Antibacterial (Helicobacter pylori) | |||
| 0.136 | 0.056 | 0.136 | Aldehyde dehydrogenase inhibitor | |||
| 0.095 | 0.015 | 0.095 | Phosphodiesterase VII inhibitor | |||
| 0.14 | 0.062 | 0.14 | NADPH oxidase inhibitor | |||
| 0.098 | 0.02 | 0.098 | NMDA receptor agonist | |||
| 0.211 | 0.132 | 0.228 | Gastrin inhibitor | 0.228 0.108 CID_154699694 | CID_154699694 | |
| 0.154 | 0.076 | 0.154 | Peroxidase inhibitor | |||
| 0.101 | 0.024 | 0.101 | Neuronal nicotinic receptor antagonist | |||
| 0.196 | 0.119 | 0.196 | DNA damaging | |||
| 0.091 | 0.014 | 0.091 | Nicotinic alpha7 receptor agonist | |||
| 0.126 | 0.05 | 0.126 | Ferrochelatase inhibitor | 0.119 0.055 CID_154699694 | ||
| 0.086 | 0.01 | 0.086 | Progesterone antagonist | |||
| 0.214 | 0.137 | 0.214 | Insulysin inhibitor | |||
| 0.15 | 0.075 | 0.15 | Cytidine deaminase inhibitor | |||
| 0.149 | 0.074 | 0.149 | GABA C receptor rho-2 antagonist | |||
| 0.123 | 0.049 | 0.123 | Estrogen antagonist | 0.116 0.063 CID_154699694 | ||
| 0.08 | 0.008 | 0.08 | Urate transporter 1 inhibitor | |||
| 0.118 | 0.046 | 0.118 | Adenylate kinase inhibitor | 0.101 0.066 CID_154699694 | ||
| 0.145 | 0.074 | 0.145 | Cyclooxygenase inhibitor | |||
| 0.11 | 0.039 | 0.11 | Potassium channel activator | |||
| 0.249 | 0.178 | 0.264 | Antibacterial | 0.264 0.164 CID_154699694 | CID_154699694 | |
| 0.091 | 0.021 | 0.091 | Phospholipase D inhibitor | |||
| 0.113 | 0.043 | 0.113 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | |||
| 0.188 | 0.118 | 0.188 | RNA-directed DNA polymerase inhibitor | |||
| 0.112 | 0.044 | 0.112 | Estrogen receptor beta antagonist | 0.107 0.05 CID_154699694 | ||
| 0.076 | 0.01 | 0.076 | DNA-dependent protein kinase inhibitor | |||
| 0.073 | 0.008 | 0.073 | Dopamine D5 agonist | |||
| 0.133 | 0.068 | 0.133 | MAO inhibitor | |||
| 0.101 | 0.037 | 0.101 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.073 | 0.009 | 0.073 | Immunoglobulin Fc receptor antagonist | |||
| 0.165 | 0.102 | 0.165 | Death-associated protein kinase 3 inhibitor | |||
| 0.083 | 0.021 | 0.083 | Glutamate (mGluR6) antagonist | 0.079 0.025 CID_154699694 | ||
| 0.072 | 0.01 | 0.072 | Phosphodiesterase 7A inhibitor | |||
| 0.216 | 0.154 | 0.216 | Transcription factor NF kappa B inhibitor | |||
| 0.104 | 0.044 | 0.104 | Triose-phosphate isomerase inhibitor | 0.086 0.066 CID_154699694 | ||
| 0.073 | 0.014 | 0.073 | Ryanodine receptor antagonist | |||
| 0.109 | 0.05 | 0.109 | Creatine kinase inhibitor | |||
| 0.113 | 0.054 | 0.113 | GABA C receptor agonist | |||
| 0.184 | 0.126 | 0.184 | MAP-kinase-activated kinase 5 inhibitor | |||
| 0.206 | 0.149 | 0.206 | Thyroid hormone beta antagonist | |||
| 0.082 | 0.025 | 0.082 | Dopamine uptake inhibitor | |||
| 0.112 | 0.055 | 0.112 | DOPA decarboxylase inhibitor | |||
| 0.082 | 0.026 | 0.082 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.078 | 0.022 | 0.078 | Nicotinic neuronal receptor agonist | |||
| 0.094 | 0.039 | 0.094 | Porphobilinogen synthase inhibitor | |||
| 0.14 | 0.085 | 0.14 | Heat shock protein 90 antagonist | |||
| 0.064 | 0.011 | 0.064 | Neurokinin 2 agonist | |||
| 0.059 | 0.006 | 0.059 | Retinoid X receptor antagonist | |||
| 0.094 | 0.041 | 0.094 | Carbonic anhydrase XIII inhibitor | |||
| 0.063 | 0.011 | 0.063 | GABA B receptor antagonist | |||
| 0.056 | 0.004 | 0.056 | ICAM 1 antagonist | |||
| 0.074 | 0.023 | 0.074 | Histone deacetylase SIRT3 inhibitor | |||
| 0.207 | 0.156 | 0.207 | Thyroid hormone antagonist | |||
| 0.141 | 0.09 | 0.141 | Hexokinase inhibitor | |||
| 0.1 | 0.05 | 0.1 | Protein kinase C zeta inhibitor | |||
| 0.068 | 0.019 | 0.068 | Thromboxane synthase inhibitor | |||
| 0.059 | 0.012 | 0.059 | Factor XIIIa inhibitor | |||
| 0.127 | 0.08 | 0.127 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.112 | 0.065 | 0.112 | Cystathionine beta-synthase inhibitor | |||
| 0.097 | 0.05 | 0.097 | Polo-like kinase-1 inhibitor | |||
| 0.055 | 0.009 | 0.055 | Glucose-6-phosphate dehydrogenase inhibitor | |||
| 0.051 | 0.006 | 0.051 | Retinoid X alpha receptor antagonist | |||
| 0.115 | 0.07 | 0.115 | Transcription factor STAT6 inhibitor | |||
| 0.065 | 0.02 | 0.065 | Leukotriene C antagonist | |||
| 0.06 | 0.016 | 0.06 | Sphingosine 1-phosphate receptor agonist | |||
| 0.062 | 0.019 | 0.062 | Squalene epoxidase inhibitor | |||
| 0.072 | 0.029 | 0.072 | Tyrosine-protein kinase EMT inhibitor | |||
| 0.098 | 0.056 | 0.098 | Potassium channel (Voltage-sensitive) activator | |||
| 0.058 | 0.016 | 0.058 | Histone deacetylase class I inhibitor | |||
| 0.055 | 0.013 | 0.055 | Retinoid X alpha receptor agonist | |||
| 0.085 | 0.043 | 0.085 | Keratolytic | |||
| 0.063 | 0.021 | 0.063 | Prolyl endopeptidase inhibitor | |||
| 0.064 | 0.023 | 0.064 | Dihydroorotate oxidase inhibitor | |||
| 0.052 | 0.012 | 0.052 | Sirtuin 2 inhibitor | |||
| 0.097 | 0.057 | 0.097 | Bile acid receptor antagonist | |||
| 0.049 | 0.01 | 0.049 | AMPA receptor agonist | |||
| 0.05 | 0.011 | 0.05 | Purinergic P2X3 antagonist | |||
| 0.043 | 0.004 | 0.043 | Factor IX inhibitor | |||
| 0.07 | 0.032 | 0.07 | Purinergic P2X1 antagonist | |||
| 0.077 | 0.039 | 0.077 | Leukotriene synthesis inhibitor | |||
| 0.103 | 0.065 | 0.137 | Expectorant | 0.137 0.041 CID_154699694 | CID_154699694 | |
| 0.069 | 0.032 | 0.069 | Transcription factor RelA inhibitor | |||
| 0.101 | 0.065 | 0.101 | Gastric antisecretory | |||
| 0.063 | 0.027 | 0.063 | Urokinase inhibitor | |||
| 0.058 | 0.022 | 0.058 | Potassium channel (Inward rectifier) activator | |||
| 0.048 | 0.012 | 0.048 | Histone deacetylase 1 inhibitor | |||
| 0.054 | 0.019 | 0.054 | Benzodiazepine antagonist | |||
| 0.087 | 0.051 | 0.087 | D-Ala-D-Ala ligase inhibitor | |||
| 0.077 | 0.042 | 0.077 | Glycine receptor agonist | |||
| 0.055 | 0.021 | 0.055 | Potassium channel (ATP-sensitive) activator | |||
| 0.049 | 0.016 | 0.049 | Vascular adhesion protein 1 inhibitor | |||
| 0.096 | 0.064 | 0.096 | Electrolyte absorption antagonist | |||
| 0.047 | 0.014 | 0.047 | Histone deacetylase 4 inhibitor | |||
| 0.064 | 0.033 | 0.064 | Alcohol oxidase inhibitor | |||
| 0.067 | 0.036 | 0.067 | Beta tubulin antagonist | |||
| 0.05 | 0.02 | 0.05 | Sphingosine 1-phosphate receptor 1 agonist | |||
| 0.034 | 0.005 | 0.034 | Complement factor 1s inhibitor | |||
| 0.051 | 0.022 | 0.051 | Geranyltranstransferase inhibitor | |||
| 0.144 | 0.115 | 0.144 | Lipocortins synthesis antagonist | |||
| 0.155 | 0.126 | 0.155 | Insulin sensitizer | |||
| 0.066 | 0.037 | 0.066 | I kappa B kinase 2 inhibitor | |||
| 0.037 | 0.009 | 0.037 | Sodium/glucose cotransporter 2 inhibitor | |||
| 0.09 | 0.062 | 0.09 | Glutamate release inhibitor | |||
| 0.04 | 0.013 | 0.04 | Histone deacetylase class II inhibitor | |||
| 0.043 | 0.016 | 0.043 | Histone deacetylase class IIa inhibitor | |||
| 0.095 | 0.068 | 0.095 | MAO A inhibitor | |||
| 0.087 | 0.06 | 0.087 | NADH dehydrogenase inhibitor | |||
| 0.04 | 0.013 | 0.04 | Histone deacetylase class IIb inhibitor | |||
| 0.04 | 0.013 | 0.04 | Histone deacetylase 6 inhibitor | |||
| 0.064 | 0.038 | 0.064 | Transcription factor AP-1 inhibitor | |||
| 0.034 | 0.008 | 0.034 | Hedgehog signaling activator | |||
| 0.081 | 0.055 | 0.081 | Glycine receptor antagonist | |||
| 0.211 | 0.185 | 0.211 | Immunosuppressant | |||
| 0.075 | 0.049 | 0.075 | Glutamate decarboxylase inhibitor | |||
| 0.076 | 0.051 | 0.076 | Acetylcholine M4 receptor antagonist | |||
| 0.09 | 0.066 | 0.09 | MAO B inhibitor | |||
| 0.043 | 0.018 | 0.043 | Leukotriene C4 antagonist | |||
| 0.062 | 0.038 | 0.062 | Protein kinase C iota inhibitor | |||
| 0.062 | 0.039 | 0.062 | Enoyl-[acyl-carrier-protein] reductase inhibitor | |||
| 0.089 | 0.065 | 0.089 | Alcohol dehydrogenase inhibitor | |||
| 0.1 | 0.077 | 0.1 | GABA receptor agonist | |||
| 0.038 | 0.015 | 0.038 | HCV polyprotein inhibitor | |||
| 0.032 | 0.009 | 0.032 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | |||
| 0.127 | 0.105 | 0.127 | Phospholipase A2 inhibitor | |||
| 0.059 | 0.038 | 0.059 | Argininosuccinate synthase inhibitor | |||
| 0.068 | 0.048 | 0.109 | Phenylalanine 4-hydroxylase inhibitor | 0.109 0.022 CID_154699694 | CID_154699694 | |
| 0.081 | 0.061 | 0.081 | GABA A receptor agonist | |||
| 0.03 | 0.011 | 0.03 | Sodium/glucose cotransporter inhibitor | |||
| 0.116 | 0.096 | 0.116 | Histone deacetylase SIRT1 inhibitor | |||
| 0.029 | 0.01 | 0.029 | Prostaglandin F2 alpha agonist | 0.022 0.017 CID_154699694 | ||
| 0.046 | 0.027 | 0.046 | Macrophage elastase inhibitor | |||
| 0.053 | 0.034 | 0.053 | Aconitate hydratase inhibitor | |||
| 0.031 | 0.013 | 0.031 | CXC chemokine 2 receptor antagonist | |||
| 0.1 | 0.083 | 0.1 | 5 Hydroxytryptamine 2B antagonist | |||
| 0.048 | 0.032 | 0.048 | Aldosterone antagonist | |||
| 0.109 | 0.092 | 0.109 | Tubulin antagonist | |||
| 0.036 | 0.02 | 0.036 | Peroxisome proliferator-activated receptor delta agonist | |||
| 0.034 | 0.017 | 0.034 | Dipeptidyl peptidase I inhibitor | |||
| 0.081 | 0.065 | 0.081 | Estrogen-related receptor beta agonist | |||
| 0.024 | 0.008 | 0.024 | Retinoid X beta receptor antagonist | |||
| 0.066 | 0.05 | 0.066 | Sirtuin 1 inhibitor | |||
| 0.055 | 0.04 | 0.055 | Carbonic anhydrase VB inhibitor | |||
| 0.047 | 0.032 | 0.047 | Potassium channel Kv1.3 blocker | |||
| 0.107 | 0.092 | 0.107 | Cyclooxygenase 1 inhibitor | |||
| 0.108 | 0.093 | 0.108 | Cathepsin H inhibitor | |||
| 0.023 | 0.009 | 0.023 | Factor XIII inhibitor | |||
| 0.073 | 0.059 | 0.073 | GABA B receptor agonist | |||
| 0.018 | 0.005 | 0.018 | Human herpes virus 5 capsid protein P40 inhibitor | |||
| 0.076 | 0.063 | 0.076 | Carbonic anhydrase VI inhibitor | |||
| 0.153 | 0.141 | 0.153 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.09 | 0.078 | 0.148 | Anabolic | 0.148 0.019 CID_154699694 | CID_154699694 | |
| 0.065 | 0.053 | 0.065 | Carbonic anhydrase VA inhibitor | |||
| 0.124 | 0.112 | 0.124 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | |||
| 0.13 | 0.119 | 0.13 | Heat shock protein 70 antagonist | |||
| 0.047 | 0.035 | 0.047 | Glucose-6-phosphate isomerase inhibitor | |||
| 0.053 | 0.041 | 0.053 | DNA helicase inhibitor | |||
| 0.087 | 0.076 | 0.087 | Sphingomyelinase inhibitor | |||
| 0.06 | 0.05 | 0.06 | Dopamine D1 antagonist | |||
| 0.072 | 0.062 | 0.072 | Macrophage migration inhibitory factor inhibitor | |||
| 0.152 | 0.142 | 0.152 | Free radical scavenger | |||
| 0.1 | 0.091 | 0.1 | Interleukin 2 antagonist | |||
| 0.078 | 0.069 | 0.078 | Acetylcholine agonist | |||
| 0.027 | 0.018 | 0.027 | Nicotinic acid receptor 2 antagonist | |||
| 0.037 | 0.029 | 0.037 | Vanilloid 3 antagonist | |||
| 0.246 | 0.238 | 0.246 | MAP kinase 1 inhibitor | |||
| 0.043 | 0.035 | 0.043 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.063 | 0.055 | 0.063 | Potassium channel large-conductance Ca-activated activator | |||
| 0.032 | 0.025 | 0.032 | Calcium release-activated channel blocker | |||
| 0.034 | 0.026 | 0.034 | Retinoid X receptor agonist | |||
| 0.106 | 0.099 | 0.106 | Bone formation stimulant | |||
| 0.019 | 0.012 | 0.019 | Progesterone agonist | |||
| 0.05 | 0.043 | 0.05 | Acyl-CoA dehydrogenase inhibitor | |||
| 0.022 | 0.015 | 0.022 | Glutamate (mGluR1a) agonist | |||
| 0.088 | 0.082 | 0.088 | GABA C receptor rho-1 antagonist | |||
| 0.077 | 0.071 | 0.077 | Histamine N-methyltransferase inhibitor | |||
| 0.139 | 0.132 | 0.139 | Neurotensin receptor agonist | |||
| 0.113 | 0.107 | 0.113 | Vanilloid 1 agonist | |||
| 0.081 | 0.076 | 0.081 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.041 | 0.036 | 0.041 | 5 Hydroxytryptamine 1A agonist | |||
| 0.065 | 0.06 | 0.065 | Aminopeptidase I inhibitor | |||
| 0.019 | 0.014 | 0.019 | Antibiotic Anthracycline-like | |||
| 0.092 | 0.087 | 0.092 | Protein-tyrosine phosphatase 1B inhibitor | |||
| 0.032 | 0.028 | 0.032 | Protein kinase (CK2) beta inhibitor | |||
| 0.044 | 0.04 | 0.044 | Plasminogen activator inhibitor antagonist | |||
| 0.059 | 0.055 | 0.059 | Neuraminidase (influenza) inhibitor | |||
| 0.059 | 0.055 | 0.059 | Carbonic anhydrase V inhibitor | |||
| 0.064 | 0.061 | 0.064 | Protein kinase C beta inhibitor | |||
| 0.032 | 0.029 | 0.032 | Benzodiazepine receptor peripheral-type antagonist | |||
| 0.084 | 0.082 | 0.084 | Xanthine oxidase inhibitor | |||
| 0.031 | 0.029 | 0.031 | RNA-directed RNA polymerase inhibitor | |||
| 0.031 | 0.029 | 0.031 | Phosphoglycerate kinase inhibitor | |||
| 0.05 | 0.048 | 0.05 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | |||
| 0.005 | 0.003 | 0.005 | Glucokinase regulatory protein inhibitor | |||
| 0.018 | 0.017 | 0.018 | Retinoic acid alpha receptor antagonist | |||
| 0.109 | 0.107 | 0.109 | Protein kinase C nu inhibitor | |||
| 0.041 | 0.039 | 0.041 | Heme oxygenase inhibitor | |||
| 0.092 | 0.091 | 0.092 | GABA C receptor antagonist | |||
| 0.122 | 0.121 | 0.122 | Polo-like kinase-3 inhibitor | |||
| 0.032 | 0.031 | 0.032 | Histone deacetylase 7 inhibitor | |||
| 0.177 | 0.176 | 0.177 | 12-Lipoxygenase inhibitor | |||
| 0.041 | 0.043 | 0.047 | Dopamine transporter inhibitor | 0.047 0.034 CID_154699694 | CID_154699694 | |
| 0.095 | 0.101 | 0.127 | Microtubule formation inhibitor | 0.127 0.054 CID_154699694 | CID_154699694 | |
| 0.031 | 0.047 | 0.043 | Glutamate (mGluR8) agonist | 0.043 0.018 CID_154699694 | CID_154699694 | |
| 0.106 | 0.124 | 0.168 | Cell wall synthesis inhibitor | 0.168 0.049 CID_154699694 | CID_154699694 | |
| 0.034 | 0.062 | 0.048 | Thromboxane antagonist | 0.048 0.044 CID_154699694 | CID_154699694 | |
| 0.074 | 0.104 | 0.108 | Lanosterol 14 alpha demethylase inhibitor | 0.108 0.044 CID_154699694 | CID_154699694 | |
| 0.012 | 0.044 | 0.128 | Estrogen receptor alpha agonist | 0.128 0.006 CID_154699694 | CID_154699694 | |
| 0.049 | 0.086 | 0.105 | Na+ K+ transporting ATPase inhibitor | 0.105 0.027 CID_154699694 | CID_154699694 | |
| 0.054 | 0.091 | 0.069 | Secretase beta inhibitor | 0.069 0.051 CID_154699694 | CID_154699694 | |
| 0.024 | 0.063 | 0.038 | Glutamate (mGluR3) agonist | 0.038 0.012 CID_154699694 | CID_154699694 | |
| 0.023 | 0.079 | 0.046 | Membrane dipeptidase inhibitor | 0.046 0.019 CID_154699694 | CID_154699694 | |
| 0.019 | 0.08 | 0.058 | Estrogen agonist | 0.058 0.031 CID_154699694 | CID_154699694 | |
| 0.072 | 0.134 | 0.14 | Cholesterol synthesis inhibitor | 0.14 0.05 CID_154699694 | CID_154699694 | |
| 0.003 | 0.07 | 0.01 | Thromboxane agonist | 0.01 0.009 CID_154699694 | CID_154699694 | |
| 0.028 | 0.124 | 0.05 | Alpha-mannosidase inhibitor | 0.05 0.044 CID_154699694 | CID_154699694 | |
| 0.095 | 0.22 | 0.196 | Hypolipemic | 0.196 0.098 CID_154699694 | CID_154699694 | |
| 0.017 | 0.18 | 0.047 | Thiazolidinedione | 0.047 0.006 CID_154699694 | CID_154699694 | |
| 0.004 | 0.215 | 0.064 | RNA-directed RNA polymerase stimulant | 0.064 0.01 CID_154699694 | CID_154699694 | |
| 0.139 | 0.383 | 0.391 | Cyclophilin D inhibitor | 0.391 0.096 CID_154699694 | CID_154699694 | |
| 0.004 | 0.29 | 0.303 | Squalene synthetase inhibitor | 0.303 0.002 CID_154699694 | CID_154699694 | |
| 0.009 | 0.307 | 0.296 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | 0.296 0.004 CID_154699694 | CID_154699694 | |
| 0.083 | 0.42 | 0.662 | Nootropic | 0.662 0.008 CID_154699694 | CID_154699694 | |
| 0.123 | 0.472 | 0.842 | Antiinflammatory | 0.842 0.01 CID_154699694 | CID_154699694 | |
| 0.11 | 0.56 | 0.45 | Calcium channel L-type activator | 0.45 0.05 CID_154699694 | CID_154699694 | |
| 0.057 | 0.589 | 0.344 | Sodium/bile acid cotransporter inhibitor | 0.344 0.043 CID_154699694 | CID_154699694 | |
| 0.027 | 0.564 | 0.25 | Vasodilator | 0.25 0.069 CID_154699694 | CID_154699694 | |
| 0.007 | 0.573 | 0.049 | p53 inhibitor | 0.049 0.014 CID_154699694 | CID_154699694 | |
| 0.007 | 0.595 | 0.376 | Aurora-A kinase inhibitor | 0.376 0.008 CID_154699694 | CID_154699694 | |
| 0.003 | 0.639 | 0.028 | Adenosine A1 receptor agonist | 0.028 0.013 CID_154699694 | CID_154699694 | |
| 0.004 | 0.664 | 0.043 | Glutamate (mGluR2) agonist | 0.043 0.016 CID_154699694 | CID_154699694 | |
| 0.005 | 0.679 | 0.047 | Glutamate (mGluR group II) agonist | 0.047 0.017 CID_154699694 | CID_154699694 | |
| 0.06 | 0.74 | 0.215 | Interleukin 2 agonist | 0.215 0.165 CID_154699694 | CID_154699694 | |
| 0.007 | 0.691 | 0.175 | Bronchodilator | 0.175 0.023 CID_154699694 | CID_154699694 | |
| 0.018 | 0.71 | 0.202 | Cardiotonic | 0.202 0.117 CID_154699694 | CID_154699694 | |
| 0.013 | 0.706 | 0.089 | Somatostatin 1 agonist | 0.089 0.043 CID_154699694 | CID_154699694 | |
| 0.063 | 0.78 | 0.226 | Peptidyltransferase inhibitor | 0.226 0.07 CID_154699694 | CID_154699694 | |
| 0.003 | 0.75 | 0.03 | 1,3-Beta-glucan synthase inhibitor | 0.03 0.015 CID_154699694 | CID_154699694 | |
| 0.02 | 0.785 | 0.91 | Analgesic | 0.91 0.004 CID_154699694 | CID_154699694 | |
| 0.003 | 0.786 | 0.295 | Secretase gamma inhibitor | 0.295 0.003 CID_154699694 | CID_154699694 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |